Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury.

Sandeep BrarKathleen D LiuAlan S GoRaymond K HsuVernon M ChinchilliSteven G CocaAmit X GargJonathan HimmelfarbTalat Alp IkizlerJames KaufmanPaul L KimmelChirag R ParikhEdward D SiewLorraine B WareHui ZengChi-Yuan Hsunull nullnull null

Published in: Clinical journal of the American Society of Nephrology : CJASN (2020)

The risk-benefit ratio of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy after hospital discharge appears to be similar regardless of whether AKI occurred during the hospitalization.

Keyphrases

angiotensin converting enzyme
acute kidney injury
angiotensin ii
cardiac surgery
stem cells
breast cancer risk